Skip to main content
Fig. 5 | BMC Neuroscience

Fig. 5

From: Protective effect of resveratrol on mitochondrial biogenesis during hyperoxia-induced brain injury in neonatal pups

Fig. 5

(A) The protein blot bands from each group of pups on PN1, PN7, and PN14. All imprints were from the same gel and the PVDF membrane was cut and regenerated according to the molecular weight of the target protein. (B) The relative expression of PGC-1α in NN, ND, NR, HN, HD, and HR groups on PN1, PN7, and PN14. (C) The relative expression of Sirt1 in NN, ND, NR, HN, HD, and HR groups on PN1, PN7, and PN14. (D) The relative expression of Nrf1 in NN, ND, NR, HN, HD, and HR groups on PN1, PN7, and PN14. (E) The relative expression of Nrf2 in NN, ND, NR, HN, HD, and HR groups on PN1, PN7, and PN14. (F) The relative expression of TFAM in NN, ND, NR, HN, HD, and HR groups at PN1, PN7, and PN14. *p < 0.05, **p < 0.001. NN, the nonhyperoxia group; ND, the nonhyperoxia with dimethyl sulfoxide group; NR, the nonhyperoxia with Res group; HN, the hyperoxia group; HD, the hyperoxia with dimethyl sulfoxide group; HR, the hyperoxia with Res group; PN1, postnatal day 1; PN7, postnatal day 7; PN14, postnatal day 14; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator-1α; Sirt1, silencing information regulator 2-related enzyme 1; Nrf1, nuclear respiratory factor 1; Nrf2, nuclear respiratory factor2; TFAM, mitochondrial transcription factor A; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Res, resveratrol.

Back to article page